A new Stanford University study reveals striking differences in brain tumor detection rates between imaging modalities. Enhanced contrast MRI identified 89% of tumors in a 284-patient cohort, compared to 72% detection with standard MRI and just 45% with CT scans.
Most significantly, the enhanced technique detected previously missed tumors in 23% of patients whose standard MRI scans appeared normal. These findings carry substantial implications for patient prognosis: earlier detection of glioblastoma could potentially improve five-year survival rates from 6.8% to 23.4%, according to epidemiological projections cited in the research.
The enhanced contrast MRI’s ability to visualize tumors as small as 2 millimeters—compared to the 5-millimeter detection threshold of conventional MRI—represents a meaningful advance in diagnostic sensitivity. Researchers emphasize that this improved detection capability could transform clinical practice when validated through planned multicenter trials beginning in 2027.
Read the full article on GMJ Newsroom.
Was this article helpful?
